ApprovalTrail

Approval · Notice of Compliance 27 · 2003

RATIO-AMCINONIDE: Notice of Compliance 27

Issued September 11, 2003

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
27
Date
September 11, 2003
Company
Ratiopharm Inc.Ulm, Germany
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
New manufacturer and product name
Therapeutic class
Topical corticosteroid

Products in this notice

BrandDINStatus today
RATIO-AMCINONIDE02247098Cancelled Post Market

Medicinal ingredients